Yüklüyor......
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations
Multiple sclerosis (MS) is among the most common chronic inflammatory diseases of the central nervous system. Although not curable, the constantly increasing armamentarium of disease-modifying drugs now allows control of disease activity in many patients. The humanized monoclonal antibody alemtuzuma...
Kaydedildi:
| Yayımlandı: | Drug Des Devel Ther |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076850/ https://ncbi.nlm.nih.gov/pubmed/27799738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S97956 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|